Contact Info

102 Avenue Gaston Roussel
Batiment Pasteur Secteur 2169
93230 Romainville - France

56 Boulevard de la Mission Marchand - 92400 Courbevoie - France

Phone: +33 6 60 90 41 24

About Regulaxis

This author has not yet filled in any details.
So far Regulaxis has created 8 entries.
2 05, 2019

2019 – Toronto, Canada – OARSI World Congress on Osteoarthritis

May 2nd, 2019|0 Comments

REGULAXIS is at the 2019 OARSI conference in Toronto from 2nd-5th of May !
Doctor Christelle Vêtu, CSO and Strategic Business Advisor will present the latest results during the poster session : “Chimeric Peptide combining both Growth Hormone and Somatostatin Sequences (REG-O3) improves function and prevents cartilage degradation in rat model of Osteoarthritis” (POSTER #611).
Meet […]

15 06, 2018

2018 – Liège, Belgium – REG-O3, the innovative therapeutic treatment for Osteoarthritis will be tested in Liège ! Partnership between REGULAXIS and ARTIALIS.

June 15th, 2018|0 Comments

Simoultaneous announcement in Paris, France and Liège, Belgium [June 25], 2018 :
Artialis, specialist in the study of the musculoskeletal disorders and Regulaxis, an innovative French company in the treatment of osteoarthritis, announce today the signing of a 1.6 million euros contract for the preclinical and clinical development of a new molecule, Reg-O3, allowing the […]

26 04, 2018

2018 – Liverpool, United Kingdom – OARSI World Congress on Osteoarthritis

April 26th, 2018|0 Comments

REGULAXIS, a leader in peptide research and development, will presents its most recent preclinical data of REG-O3, an innovative chimeric peptide for the treatment of osteoarthritis of knee at the 2018 Osteoarthritis Research Society International World Congress, to be held April 26-29, 2018 in Liverpool, UK.

18 04, 2014

2014 – Regulaxis in the French Magazine “Challenges”

April 18th, 2014|0 Comments

Regulaxis SAS is proud to announce that it has been selected by the economy newspaper Challenge in its issue of 17-23 April 2014 for the 2014 edition of its record of 100 French start-ups in which it is advisable to invest.

7 10, 2013

2013 – Paris, France – REGULAXIS at The Universal Biotech Innovation Prize

October 7th, 2013|0 Comments

The Universal Biotech Innovation Prize is open to Small and Medium Enterprises from Europe and China and to academics researchers on preventive and curative therapies, medical devices, technological tools.
Regulaxis project finished 15th on 81 companies  from 16 european countries at the the Universal Biotech Innovation Prize.

11 09, 2013

2013 – Bobigny, France – REGULAXIS SAS is officially incorporated as a French company based in BIOCITECH, Romainville, France.

September 11th, 2013|0 Comments

Regulaxis is officially incorporated as a French company based at Biocitech life science park and hire its first employee.

2 07, 2013

2013 – REGULAXIS awarded in emergeance category at the French Research Minister “Concours national”

July 2nd, 2013|0 Comments

Regulaxis won a prize of the “15eme concours national d’aide à la création d’entreprises de technologies innovantes” organize by the French Research Ministery in emergeance category.
The money prize is 20.000€ and participate to the launch of the company.
On the 175 winners this year only 3 were coming from biotech companies proposing the development of […]

1 04, 2012

2012 – Bondy, France – REGULAXIS SAS at the start-up incubator Bond’innov

April 1st, 2012|0 Comments

Regulaxis project is incubated at Bond’innov to launch this new story in the best way.
Bond’innov is the first incubator in Seine-Saint-Denis aera, which is located in IRD campus of Bondy www.ird.fr.